The rise in prevalence of cancer, inherited disorders, viral infections, Alzheimer’s, Parkinson’s, rheumatoid arthritis are the major growth factors for viral vector and plasmid DNA assembleing market. Besides, the growing number of gene modified therapies like Yescarta and Kymriah are also fueling the market growth. According to the current analysis of Reports and...